{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:27:46Z","timestamp":1789583266613,"version":"build-2803163510"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the last decades the molecular basis of monogenic diseases has been largely unraveled, although their treatment has often remained unsatisfactory. Autosomal recessive osteopetrosis (ARO) belongs to the small group of genetic diseases that are usually treated with hematopoietic stem cell transplantation (HSCT). However, this approach is not effective in the recently identified form carrying mutations in the receptor activator of NF-\u03baB ligand (RANKL) gene. In this subset, therapy replacement approach based on RANKL delivery has a strong rationale. Here we demonstrate that the systematic administration of RANKL for 1 month to Rankl\u2212\/\u2212 mice, which closely resemble the human disease, significantly improves the bone phenotype and has beneficial effects on bone marrow, spleen and thymus; major adverse effects arise only when mice are clearly overtreated. Overall, we provide evidence that the pharmacological administration of RANKL represents the appropriate treatment option for RANKL-deficient ARO patients, to be validated in a pilot clinical trial. \u00a9 2012 American Society for Bone and Mineral Research.<\/jats:p>","DOI":"10.1002\/jbmr.1712","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T05:01:52Z","timestamp":1343365312000},"page":"2501-2510","source":"Crossref","is-referenced-by-count":51,"title":["Osteopetrosis rescue upon RANKL administration to <i>Rankl<\/i>\u2212<i>\/<\/i>\u2212 mice: A new therapy for human RANKL-dependent ARO"],"prefix":"10.1093","volume":"27","author":[{"given":"Nadia","family":"Lo Iacono","sequence":"first","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry C","family":"Blair","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Centre and Department of Pathology and of Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro L","family":"Poliani","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Marrella","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ficara","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Cassani","sequence":"additional","affiliation":[{"name":"Fondazione Humanitas per la Ricerca, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchetti","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Fontana","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Brescia, Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo M","family":"Guerrini","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Traggiai","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Rheumatic Disease, Istituto G. Gaslini IRCCS, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Schena","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Rheumatic Disease, Istituto G. Gaslini IRCCS, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Paulis","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Mantero","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Inforzato","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Valaperta","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pangrazio","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crisafulli","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Maina","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kostenuik","sequence":"additional","affiliation":[{"name":"Metabolic Disorders Research, Amgen, Inc., Thousand Oaks, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vezzoni","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Villa","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Sobacchi","sequence":"additional","affiliation":[{"name":"Humanitas Clinical and Research Center, Rozzano, Italy"},{"name":"UOS\/IRGB, Milan Unit, CNR, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"2024020318323217500_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0022-3476(05)82004-9","article-title":"Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group","volume":"125","author":"Gerritsen","year":"1994","journal-title":"J Pediatr."},{"key":"2024020318323217500_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bmt.1704194","article-title":"Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report","volume":"32","author":"Driessen","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"2024020318323217500_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/sj.bmt.1705533","article-title":"Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen","volume":"38","author":"Tolar","year":"2006","journal-title":"Bone Marrow Transplant."},{"key":"2024020318323217500_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajh.21447","article-title":"A single-center experience in 20 patients with infantile malignant osteopetrosis","volume":"84","author":"Mazzolari","year":"2009","journal-title":"Am J Hematol."},{"key":"2024020318323217500_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-008-9196-4","article-title":"Infantile malignant, autosomal recessive osteopetrosis: the rich and the poor","volume":"84","author":"Villa","year":"2009","journal-title":"Calcif Tissue Int."},{"key":"2024020318323217500_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ng2076","article-title":"Osteoclast-poor human osteopetrosis due to mutations in RANKL","volume":"39","author":"Sobacchi","year":"2007","journal-title":"Nat Genet."},{"key":"2024020318323217500_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med."},{"key":"2024020318323217500_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med."},{"key":"2024020318323217500_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell."},{"key":"2024020318323217500_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1083\/jcb.145.3.527","article-title":"The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts","volume":"145","author":"Burgess","year":"1999","journal-title":"J Cell Biol."},{"key":"2024020318323217500_bib11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","article-title":"Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo","volume":"157","author":"Lacey","year":"2000","journal-title":"Am J Pathol."},{"key":"2024020318323217500_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00223-008-9133-6","article-title":"Soluble RANKL induces high bone turnover and decreases bone volume, density, and strength in mice","volume":"82","author":"Lloyd","year":"2008","journal-title":"Calcif Tissue Int."},{"key":"2024020318323217500_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.cell.2007.12.037","article-title":"Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals","volume":"132","author":"Shinohara","year":"2008","journal-title":"Cell."},{"key":"2024020318323217500_bib14","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1359\/jbmr.090217","article-title":"Evaluation of pharmaceuticals with a novel 50-hour animal model of bone loss","volume":"24","author":"Tomimori","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024020318323217500_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00198-010-1283-5","article-title":"Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study","volume":"22","author":"Campbell","year":"2011","journal-title":"Osteoporos Int."},{"key":"2024020318323217500_bib16","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1073\/pnas.200294797","article-title":"Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024020318323217500_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2353\/ajpath.2009.080688","article-title":"Fetal liver cells transplanted in utero rescue the osteopetrotic phenotype in the oc\/oc mouse","volume":"174","author":"Tondelli","year":"2009","journal-title":"Am J Pathol."},{"key":"2024020318323217500_bib18","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI30928","article-title":"A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome","volume":"117","author":"Marrella","year":"2007","journal-title":"J Clin Invest."},{"key":"2024020318323217500_bib19","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res."},{"key":"2024020318323217500_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.stem.2008.03.004","article-title":"Pbx1 regulates self-renewal of long-term hematopoietic stem cells by maintaining their quiescence","volume":"2","author":"Ficara","year":"2008","journal-title":"Cell Stem Cell."},{"key":"2024020318323217500_bib21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature."},{"key":"2024020318323217500_bib22","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1084\/jem.20062497","article-title":"RANKL signals from CD4+CD3- inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla","volume":"204","author":"Rossi","year":"2007","journal-title":"J Exp Med."},{"key":"2024020318323217500_bib23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.immuni.2008.06.018","article-title":"The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator","volume":"29","author":"Hikosaka","year":"2008","journal-title":"Immunity."},{"key":"2024020318323217500_bib24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaci.2011.04.030","article-title":"Gene therapy for primary adaptive immune deficiencies","volume":"127","author":"Fischer","year":"2011","journal-title":"J Allergy Clin Immunol."},{"key":"2024020318323217500_bib25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1600-0714.1989.tb00755.x","article-title":"Effects of bone marrow transplantation on impacted dental germs in osteopetrotic op\/op rats","volume":"18","author":"Philippart","year":"1989","journal-title":"J Oral Pathol Med."},{"key":"2024020318323217500_bib26","doi-asserted-by":"crossref","first-page":"14629","DOI":"10.1073\/pnas.0507637102","article-title":"Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero","volume":"102","author":"Frattini","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2024020318323217500_bib27","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1182\/blood-2006-12-061382","article-title":"Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc\/oc mice","volume":"109","author":"Johansson","year":"2007","journal-title":"Blood."},{"key":"2024020318323217500_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bmt.1703416","article-title":"Dental development after successful treatment of infantile osteopetrosis with bone marrow transplantation","volume":"29","author":"J\u00e4levik","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"2024020318323217500_bib29","first-page":"39","article-title":"Malignant infantile osteopetrosis: dental effects in pediatric patients","volume":"7","author":"Luzzi","year":"2006","journal-title":"Case reports. Eur J Paediatr Dent."},{"key":"2024020318323217500_bib30","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1597\/07-203.1","article-title":"Maxillofacial aspects in malignant osteopetrosis","volume":"46","author":"da Silva Santos","year":"2009","journal-title":"Cleft Palate Craniofac J."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.1712","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/12\/2501\/56561087\/1712_ftp.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/27\/12\/2501\/56561087\/1712_ftp.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:47:31Z","timestamp":1710341251000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/27\/12\/2501-2510\/7598371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,26]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,7,26]]},"published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.1712","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,12,1]]},"published":{"date-parts":[[2012,7,26]]}}}